Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reconsolidation Therapy With Propranolol as a Novel Treatment for Chronic Pain : a Placebo-controlled Feasibility Study

NCT05085782 is registered in ClinicalTrials.gov with Université de Sherbrooke as lead sponsor.

NCT NCT05085782
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05085782 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reconsolidation Therapy With Propranolol as a Novel Treatment for Chronic Pain : a Placebo-controlled Feasibility Study
Lead sponsor
Université de Sherbrooke
Phase
Phase 2
Overall status
Completed
Start date
February 7, 2022
Completion date
August 31, 2025
Enrollment
48 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic low-back pain, fibromyalgia